Compare AbCellera Biologics Inc (ABCL) vs Duolingo Inc (DUOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Duolingo Inc — how do they compare? AbCellera Biologics Inc trades at $9.25 (market cap $2.99B), while Duolingo Inc trades at $134 (market cap $6.34B). The key difference: Duolingo Inc is far larger — about 2.1× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | DUOL | |
|---|---|---|
Market Cap | $2.99B | $6.34B |
Sector | Health | Technology |
52-Week High | $9.76 | $369.19 |
52-Week Low | $2.78 | $90.03 |
Enterprise Value | $2.58B | $5.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →
